Advertisement

Archives of Virology

, Volume 163, Issue 6, pp 1559–1566 | Cite as

Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection

  • Zahra Tajik
  • Farah Bokharaei-Salim
  • Saied Ghorbani
  • Hossein Keyvani
  • Maryam Esghaei
  • Seyed Hamidreza Monavari
  • Angila Ataei-Pirkooh
  • Saba Garshasbi
  • Tahereh Donyavi
  • Atousa Fakhim
Original Article
  • 128 Downloads

Abstract

The presence of hepatitis B virus (HBV) DNA in the absence of traceable hepatitis B surface antigen (HBsAg) in the plasma specimen of patients is defined as occult HBV infection (OBI). This study aimed to detect HBV-DNA in the plasma and peripheral blood mononuclear cells (PBMCs) of Iranian HBsAg negative patients with human immunodeficiency virus (HIV) infection. This cross-sectional study was conducted on 172 patients with HIV infection from September 2015 to August 2017. The patients were tested for serological parameters (HBsAg, HBcAb, HBeAg and HBeAb) against HBV infection. Moreover, they were tested for HBV viral load (using COBAS TaqMan 48 Kit, Roche, USA) in plasma and the presence of the HBV genome in PBMC specimens using real-time PCR. The mean age of the patients was 35.4 ± 13.4 years. Of the 172 studied patients, 109 (63.4%) were male. In this study, 151 (87.8%) patients were negative for HBsAg, 111 (64.5%) patients were negative for all HBV infection serological markers, 9 (5.2%) patients were only positive for HBsAg and 29 (16.9%) patients were only positive for HBcAb. Moreover, five (3.3%) patients with HBsAg negative had OBI (in the plasma sample of four patients and PBMC specimens of all five patients, HBV-DNA was detected). The present study revealed that 3.3% of the patients with HIV infection had occult HBV infection. Presumably, designing prospective studies to identify this infection in patients with HIV infection is informative and valuable.

Notes

Acknowledgments

The authors of the present research would like to thank all the candidates who enrolled in this study.

Sources of funding

The current study was financially supported by Research Deputy of Iran University of Medical Sciences (grant number: 27008).

Compliance with ethical standards

Conflicts of interest

The authors of the current research declare no conflict(s) of interest.

Ethical considerations

Ethical approval for the current study was received from the local ethics committee of the Iran University of Medical Sciences (IUMS), Tehran, Iran. All of the participants were informed about the present research, with a written consent form obtained from them prior to their enrollment. All the experiments were done in the HIV Laboratory of National Centre, Vice Chancellor for Health, IUMS, Tehran, Iran.

References

  1. 1.
    Chen GF, Wang C, Lau G (2017) Treatment of chronic hepatitis B infection-2017. Liver Int 37(S1):59–66CrossRefPubMedGoogle Scholar
  2. 2.
    Amitis R, Mohammad B, Ali E, Masoomeh S, Arezoo A (2012) Occult hepatitis B infection in different high risk patients. Hepat Mon 2012:467–468Google Scholar
  3. 3.
    Chemin I, Trepo C (2005) Clinical impact of occult HBV infections. J Clin Virol 34:S15–S21CrossRefPubMedGoogle Scholar
  4. 4.
    Raimondo G, Allain J-P, Brunetto MR, Buendia M-A, Chen D-S, Colombo M et al (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49(4):652–657CrossRefPubMedGoogle Scholar
  5. 5.
    Hu KQ (2002) Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 9(4):243–257CrossRefPubMedGoogle Scholar
  6. 6.
    Sood A, Pangotra C, Manrai M (2016) Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital. Medi J Armed Forces India. 72(2):140–144CrossRefGoogle Scholar
  7. 7.
    Bokharaei-Salim F, Keyvani H, Monavari SH, Esghaei M, Fakhim S, Ataei Pirkooh A et al (2014) Distribution of hepatitis B virus genotypes in azerbaijani patients with chronic hepatitis B infection. Hepat Mon 14(12):e25105CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Gupta S, Singh S (2010) Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India. BMC Infect Dis 10(1):53CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    hio CL, editor Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. In: Seminars in liver disease; 2003: Copyright© 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.:+ 1 (212) 584-4662.Google Scholar
  10. 10.
    Diop-Ndiaye H, Touré-Kane C, Etard J-F, Lo G, Diaw P, Ngom-Gueye N et al (2008) Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). J Med Virol 80(8):1332–1336CrossRefPubMedGoogle Scholar
  11. 11.
    Peters MG (2007) Diagnosis and management of hepatitis B virus and HIV coinfection. Topics HIV Med Publ Int AIDS Soc USA 15(5):163Google Scholar
  12. 12.
    Hofer M, Joller-Jemelka H, Grob P, Lüthy R, Opravil M (1998) Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 17(1):6–13CrossRefPubMedGoogle Scholar
  13. 13.
    Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour J-B et al (2002) The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 36(5):681–686CrossRefPubMedGoogle Scholar
  14. 14.
    Bloquel B, Jeulin H, Burty C, Letranchant L, Rabaud C, Venard V (2010) Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. J Med Virol 82(2):206–212CrossRefPubMedGoogle Scholar
  15. 15.
    Vallet-Pichard A, Pol S (2006) Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol 44:S28–S34CrossRefPubMedGoogle Scholar
  16. 16.
    Tramuto F, Maida CM, Colomba GM, Di Carlo P, Mazzola G, Vecchi VL et al (2013) Occult hepatitis B infection in the immigrant population of sicily, Italy. J Immigr Minor Health 15(4):725–731CrossRefPubMedGoogle Scholar
  17. 17.
    Yousif M, Mudawi H, Hussein W, Mukhtar M, Nemeri O, Glebe D et al (2014) Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan. Int J Infect Dis 29:125–132CrossRefPubMedGoogle Scholar
  18. 18.
    Allain J-P (2017) Global epidemiology of occult HBV infection. Ann Blood. 2(7):1–13Google Scholar
  19. 19.
    Kremsdorf D, Soussan P, Paterlini-Brechot P, Brechot C (2006) Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene. 25(27):3823–3833CrossRefPubMedGoogle Scholar
  20. 20.
    Tramuto F, Maida CM, Colomba GM, Di Carlo P, Mazzola G, Vecchi VL et al (2013) Occult hepatitis B infection in the immigrant population of sicily, Italy. J Immigr Minority Health. 15(4):725–731CrossRefGoogle Scholar
  21. 21.
    Tajik Z, Keyvani H, Bokharaei-Salim F, Zolfaghari MR, Fakhim S, Keshvari M et al (2015) Detection of Hepatitis B virus covalently closed circular DNA in the plasma of Iranian HBeAg-negative patients with chronic hepatitis B. Hepat Mon. 15(9):e30790CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Garson JA, Grant PR, Ayliffe U, Ferns RB, Tedder RS (2005) Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods. 126(1–2):207–213CrossRefPubMedGoogle Scholar
  23. 23.
    Keyvani H, Taghinezhad Saroukalaei S, Mohseni AH (2016) Assessment of the human cytomegalovirus UL97 gene for identification of resistance to ganciclovir in iranian immunosuppressed patients. Jundishapur J Microbiol 9(5):e31733CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Zuckerman AJ (2000) Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet. 355(9213):1382–1384CrossRefPubMedGoogle Scholar
  25. 25.
    Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A et al (2004) Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 126(1):102–110CrossRefPubMedGoogle Scholar
  26. 26.
    Twu SJ, Detels R, Nelson K, Visscher BR, Kaslow R, Palenicek J et al (1993) Relationship of hepatitis B virus infection to human immunodeficiency virus type 1 infection. J Infect Dis 167(2):299–304CrossRefPubMedGoogle Scholar
  27. 27.
    Treitinger A, Spada C, Silva EL, Miranda A, Oliveira OV, Silveira M et al (1999) Prevalence of serologic markers of HBV and HCV infection in HIV-1 seropositive patients in Florianópolis, Brazil. Braz J Infect Dis. 3(1):1–5PubMedGoogle Scholar
  28. 28.
    Souza MGd, Passos ADC, Machado AA, Figueiredo JFDC, Esmeraldino LE (2004) HIV and hepatitis B virus co-infection: prevalence and risk factors. Revista da Sociedade Brasileira de Medicina Tropical. 37(5):391–395CrossRefPubMedGoogle Scholar
  29. 29.
    Araujo NM, Branco-Vieira M, Silva A, Pilotto JH, Grinsztejn B, De Almeida AJ et al (2008) Occult hepatitis B virus infection in HIV-infected patients: evaluation of biochemical, virological and molecular parameters. Hepatol Res. 38(12):1194–1203PubMedGoogle Scholar
  30. 30.
    Monteiro MRDCC, Nascimento MMPD, Passos ADC, Figueiredo JFDC (2004) Soroepidemiological survey of hepatitis B virus among HIV/AIDS patients in Belém, Pará-Brasil. Revista da Sociedade Brasileira de Medicina Tropical. 37:27–32CrossRefPubMedGoogle Scholar
  31. 31.
    de Almeida Pereira RAR, Mussi ADH, e Silva VCDA, Souto FJD (2006) Hepatitis B Virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil. BMC Infect Dis 6(1):34CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Koblin BA, Taylor PE, Rubinstein P, Stevens CE (1992) Effect of duration of hepatitis B virus infection on the association between human immunodeficiency virus type-1 and hepatitis B viral replication. Hepatology. 15(4):590–592CrossRefPubMedGoogle Scholar
  33. 33.
    Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A et al (1999) Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 29(4):1306–1310CrossRefPubMedGoogle Scholar
  34. 34.
    Sadeghi A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, Poortahmasebi V, Poorebrahim M et al (2017) HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg. J Med Virol 89(2):246–256CrossRefPubMedGoogle Scholar
  35. 35.
    Jahanbakhsh A, Farzinepoor Z, Mansouri F, Vaziri S, Afsharian M (2017) Prevalence of Occult Hepatitis B in HIV Positive Patients (Adolescents and Adults) in Kermanshah-Iran. Int J Pediatrics. 5(9):5797–5803Google Scholar
  36. 36.
    Aghakhani A, Mohraz M, Aghasadeghi MR, Banifazl M, Vahabpour R, Karami A et al (2016) Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination. Int J STD AIDS. 27(11):967–972CrossRefPubMedGoogle Scholar
  37. 37.
    Honarmand A, Pourahmad M, Solhjoo K, Kohan M, Davami MH, Mostafavi Zadeh SK (2014) Occult hepatitis B demonstrated by anti-HBc and HBV DNA in HIV-positive patients. Reports Biochem Mol Biol 3(1):38–42Google Scholar
  38. 38.
    Ramezani A, Banifazl M, Eslamifar A, Aghakhani A (2010) Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 4(10):658–661PubMedGoogle Scholar
  39. 39.
    Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A et al (2008) Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Intervirology. 51(4):270–274CrossRefPubMedGoogle Scholar
  40. 40.
    Schaefer S (2007) Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14–21CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Köck J, Theilmann L, Galle P, Schlicht H (1996) Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology. 23(3):405–413PubMedGoogle Scholar
  42. 42.
    Cassini R, De Mitri M, Gibellini D, Urbinati L, Bagaglio S, Morsica G et al (2013) A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. J Viral Hepat 20(1):42–49CrossRefPubMedGoogle Scholar
  43. 43.
    Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M et al (2007) Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. J Med Virol 79(10):1464–1471CrossRefPubMedGoogle Scholar
  44. 44.
    Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A et al (2006) Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. Aids. 20(9):1253–1260CrossRefPubMedGoogle Scholar
  45. 45.
    Shire NJ, Rouster SD, Rajicic N, Sherman KE (2004) Occult hepatitis B in HIV-infected patients. JAIDS J Acquir Immune Defic Syndr 36(3):869–875CrossRefPubMedGoogle Scholar
  46. 46.
    Fabbri G, Mastrorosa I, Vergori A, Mazzotta V, Pinnetti C, Grisetti S et al (2017) Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature. BMC Infect Dis. 17(1):182CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Opaleye OO, Oluremi AS, Atiba AB, Adewumi MO, Mabayoje OV, Donbraye E et al (2014) Occult Hepatitis B Virus infection among HIV positive patients in Nigeria. J Trop Med. 2014:796121CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Panigrahi R, Majumder S, Gooptu M, Biswas A, Datta S, Chandra PK et al (2012) Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. Ann Hepatol 11(6):870–875PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  • Zahra Tajik
    • 1
  • Farah Bokharaei-Salim
    • 1
    • 2
  • Saied Ghorbani
    • 2
  • Hossein Keyvani
    • 2
  • Maryam Esghaei
    • 2
  • Seyed Hamidreza Monavari
    • 2
  • Angila Ataei-Pirkooh
    • 2
  • Saba Garshasbi
    • 1
  • Tahereh Donyavi
    • 1
  • Atousa Fakhim
    • 3
  1. 1.HIV Laboratory of National CenterIran University of Medical SciencesTehranIran
  2. 2.Department of Virology, School of MedicineIran University of Medical SciencesTehranIran
  3. 3.Department of Architectural Engineering, Faculty of EngineeringIslamic Azad UniversityTehranIran

Personalised recommendations